Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: MacroRisk Analytics/EconomicInvestor

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Quest Diagnostics Inc gives FY 2014 guidance below analysts' estimates - Conference Call

Thursday, 30 Jan 2014 08:30am EST 

Quest Diagnostics Inc:Expects FY 2014 revenues growth to be flat to down 2 percent excluding the impact of Solstas and diluted EPS to be $3.90 - $4.10.The Company reported revenue of $7.146 billion in FY 2013.FY 2014 revenue of $7.151 billion and EPS of $4.18- Thomson Reuters I/B/E/S. 

Company Quote

0.15 +0.24%
4:03pm EDT